LP199556-4
Lurasidone
Active
Description
Lurasidone (brandname Latuda) is an atypical antipsychotic used to treat the symptoms of schizophrenia and depressive episodes associated with bipolar I disorder. It can be used alone or in combination with lithium or valproate. Movement abnormalities, akathisia, Parkinsonism, dystonia, as well as agitation, anxiety, somnolence, nausea and drowsiness are the most frequent adverse effects. PMID: 31082101 As of September 2019, lurasidone has a black box warning for "increased mortality in elderly patients with dementia-related psychosis; and suicidal thoughts and behaviors." [https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/200603lbls10s11.pdf] Source: Regenstrief LOINC
Basic Part Properties
- Part Name
- Lurasidone
- Part Display Name
- Lurasidone
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2015-07-23
- Construct for LOINC Short Name
- Lurasidone
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP199556-4 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP199556-4
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
zh-CN | Chinese (China) | 鲁拉西酮 Synonyms: 罗西酮; |
es-ES | Spanish (Spain) | Lurasidona |
it-IT | Italian (Italy) | Lurasidone |
tr-TR | Turkish (Turkey) | Lurasidon |
nl-NL | Dutch (Netherlands) | lurasidon |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright © Regenstrief Institute, Inc. and the Logical Observation Identifiers Names and Codes (LOINC) Committee. See https://